It appears imminent that Great Britain, once the home of the EMA will leave or exit the European Union. This event–while still pending–will have a huge and game changing impact on the life sciences industry. This session will explore measures already put in place and well as those anticipated to prepare for the effects of Brexit.

• Examining changes which the European Medicines Agency (EMA) will put into effect to account for Great Britain’s departure
• Exploring guidelines Great Britain will put into effect to regulate the life sciences industry
• Analyzing policies life sciences companies must implement to comply with the impact of Brexit